Skip to main content

News

DYNA Robotics Launches Semi-Humanoid Robot for Full Commercial Shifts

Image
DYNA Robotics Launches Semi-Humanoid Robot for Full Commercial Shifts

Redwood City, Calif. – September 29, 2026 -- DYNA Robotics has launched the DYNA 2.1 physical agent, a semi-humanoid robot capable of autonomously completing full commercial workflows -- including entire laundry shifts -- without human intervention. The system is now deployed in hotels, laundromats, and restaurants.

DYNA 2.1 runs on a proprietary model trained on one million hours of data

The robot's hardware pairs an upper torso with two arms -- compatible with parallel-jaw grippers or dexterous hands -- and four steerable wheels for mobility without toppling risk. It is powered by DYNA's world action model, DYNA 2, trained on a million hours of human and robot data, combined with a vision-language orchestrator for workflow reasoning and a whole-body controller that unifies driving, reaching, bending, and lifting into single fluid motions.

Sonic Tools USA Launches Free Configurator for 163 Foam Modules

Image
Sonic Tools USA Launches Free Configurator for 163 Foam Modules

Auburn, Ala. – September 29, 2026 -- Sonic Tools USA has rolled out a free online configurator letting technicians build custom toolbox layouts from 163 Sonic Foam System (SFS) modules across five size categories, cutting toolbox setup guesswork for automotive, aviation and manufacturing crews.

Configurator maps 163 SFS modules across extra-small to extra-large drawers

The tool works drawer by drawer across Sonic's S-Series Toolboxes and boxes from other manufacturers, using exact drawer dimensions with drag-and-drop and rotation features so users can arrange modules like a puzzle. A utilization bar tracks available space in real time, while keyword search by SKU or foam size speeds selection.

Registered users can build and save multiple configurations, revisit them later, and export a finished layout as a PDF "Build Report" for procurement or internal records.

Acurx Enrolls First Patient in PATHFINDER Trial for Recurrent C. diff

Staten Island, N.Y. – September 29, 2026 -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) has enrolled the first patient in its PATHFINDER clinical trial evaluating ibezapolstat in patients with multiply-recurrent Clostridioides difficile infection (rCDI), a condition affecting up to 40% of patients treated with vancomycin after multiple prior episodes.

Fully funded pilot trial targets approximately 20 patients with severe recurrence history

The Phase 2 PATHFINDER study is a multicenter, open-label, single-arm trial enrolling patients who have experienced at least three CDI episodes within the past 12 months. Participants receive ibezapolstat for 14 days, with assessments for Clinical Cure at Day 16, Sustained Clinical Cure at Day 42, and recurrence rates tracked through Week 24.

Wyndham Hotels Boosts Buyback Authorization by $400 Million

Image
Wyndham Hotels Boosts Buyback Authorization by $400 Million

Parsippany, N.J. – September 29, 2026 -- Wyndham Hotels & Resorts (NYSE: WH) said its Board of Directors approved a $400 million increase to the company's share repurchase authorization, expanding capital returned to shareholders.

Board cites cash-flow strength behind expanded buyback plan

President and CEO Geoff Ballotti said the increase reflects the Board's confidence in Wyndham's business model and its ability to generate significant cash flow. The program carries no termination date and can be suspended or discontinued at any time.

Repurchase execution remains flexible and market-dependent

Wyndham said the amount and timing of specific repurchases will depend on market conditions, applicable legal requirements and other factors. Buybacks may be executed through open market purchases or privately negotiated transactions.

IGT Unveils Queen-Themed Slot Game on New Summit75 Cabinet

Image
IGT Unveils Queen-Themed Slot Game on New Summit75 Cabinet

Las Vegas – September 29, 2026 -- IGT debuted Queen Video Slots at the 2026 Global Gaming Expo (G2E), a new casino game built on the legacy of rock band Queen and launched on the company's new Summit75 cabinet.

IGT partners with Sony Music subsidiary to license Queen catalog for slot game

IGT developed the title in collaboration with Ceremony of Roses, Queen's licensor and a global subsidiary of Sony Music Entertainment. The game features 10 Queen tracks, including "We are the Champions," "Bohemian Rhapsody," and "Don't Stop Me Now," alongside photos and videos of all four original band members.

Game includes four bonuses and six jackpots to drive floor engagement

Queen Video Slots offers four content-rich bonus rounds and six jackpot tiers, positioned by IGT as a concert-like experience designed to capture both music fans and slot players on casino floors.

VIAVI Launches CF50, Smallest 100G Test Platform with Native PQC

Image
VIAVI Launches CF50, Smallest 100G Test Platform with Native PQC

Chandler, Arizona – September 29, 2026 -- VIAVI Solutions Inc. (NASDAQ: VIAV) has launched the CyberFlood CF50, billed as the industry's smallest and lightest all-in-one platform for enterprise-scale application performance, security and AI inference testing at speeds up to 100G.

CF50 delivers TLS performance 1.75X faster than nearest competitor

The 1U appliance combines Layer 4-7 traffic generation, security assessment and AI inference testing while offering what VIAVI describes as the industry's lowest power consumption. It includes native support for Post-Quantum Cryptography (PQC), addressing enterprise migration toward quantum-resistant encryption standards.

RCP to Honor 1,250 Custodial Workers at 11 U.S. Events

Image
RCP to Honor 1,250 Custodial Workers at 11 U.S. Events

Huntersville, N.C. – September 29, 2026 -- Rubbermaid Commercial Products (RCP) will host 11 appreciation events across the United States ahead of National Custodian Day on October 2, personally recognizing an estimated 1,250 custodial and facility maintenance professionals.

RCP marks fifth year of Behind the Scenes of Clean initiative

The program, launched in 2022, has hosted more than 250 recognition events nationwide and honored around 25,000 custodial and facility maintenance professionals since inception, according to the company, a unit of Newell Brands.

Events span cities including Mooresville, Atlanta, Orlando, Chicago and Naples

Local teams working across workplaces, healthcare facilities, public spaces, hospitality venues, transportation hubs and entertainment destinations will be recognized face-to-face at the 11 gatherings.

Coldspring Launches First National Cremation Placement Day for Oct. 17

Cold Spring, Minn. – September 29, 2026 -- More than 20 million Americans currently keep a loved one's cremated remains at home or pass them between generations without a permanent memorial site, according to data cited by Minnesota-based stone and bronze fabricator Coldspring. The company has established and registered the first-ever National Cremation Placement Day, set for Saturday, October 17, 2026, to address the gap.

Coldspring registers new annual observance tied to cremation's 150th U.S. anniversary

The date coincides with the 150th anniversary of cremation practice in America. Coldspring has designated the observance to recur annually on the third Saturday of October, giving the funeral and memorialization sector a recurring calendar event.

Lilly's Zepbound 15 mg Outpaces Wegovy HD by 4.5% in New Weight-Loss Analysis

Image
Lilly's Zepbound 15 mg Outpaces Wegovy HD by 4.5% in New Weight-Loss Analysis

Indianapolis – September 29, 2026 -- Eli Lilly and Company said a new indirect treatment comparison shows Zepbound (tirzepatide) 15 mg produced 4.5% greater body-weight loss than Novo Nordisk's Wegovy HD (semaglutide 7.2 mg) in adults with obesity, intensifying the competitive battle in the obesity-drug market. The 10 mg dose of Zepbound delivered 3.2% greater weight reduction than Wegovy HD, according to data presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan.

Providence Therapeutics Forms Oncology Advisory Board for mRNA Vaccines

Calgary – September 29, 2026 -- Providence Therapeutics Holdings, Inc. has formed its first Clinical Advisory Board to guide development of its therapeutic mRNA cancer vaccine programs, including a personalized vaccine for pediatric brain cancer and off-the-shelf precision therapies for solid tumors.

Chief Medical Officer Leon Rozen chairs new four-member advisory panel

Dr. Rozen leads the board, which brings in Ezra Cohen, MD; Melinda Merchant, MD, PhD; and John Powderly, MD, to steer clinical strategy for the company's cancer vaccine pipeline.

Tempus AI oncology chief joins board with immunotherapy track record

Ezra Cohen currently serves as Chief Medical Officer for Oncology at Tempus AI. He previously held roles as Professor of Medicine and Division Chief of Hematology/Oncology at the Moores Cancer Center, University of California, San Diego.